Clinical trial
Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
NCT00165750 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- November 30, 2008
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease